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Background: Chorioamnionitis, inflammation of the fetal membranes during pregnancy,
is often caused by intra-amniotic (IA) infection with single or multiple microbes.
Chorioamnionitis can be either acute or chronic and is associated with adverse postnatal
outcomes of the intestine, including necrotizing enterocolitis (NEC). Neonates with NEC
have structural and functional damage to the intestinal mucosa and the enteric nervous
system (ENS), with loss of enteric neurons and glial cells. Yet, the impact of acute,
chronic, or repetitive antenatal inflammatory stimuli on the development of the intestinal
mucosa and ENS has not been studied. The aim of this study was therefore to investigate
the effect of acute, chronic, and repetitive microbial exposure on the intestinal mucosa,
submucosa and ENS in premature lambs.
Materials and Methods: A sheep model of pregnancy was used in which
the ileal mucosa, submucosa, and ENS were assessed following IA exposure to
lipopolysaccharide (LPS) for 2 or 7 days (acute), Ureaplasma parvum (UP) for 42 days
(chronic), or repetitive microbial exposure (42 days UP with 2 or 7 days LPS).
Results: IA LPS exposure for 7 days or IA UP exposure for 42 days caused intestinal
injury and inflammation in the mucosal and submucosal layers of the gut. Repetitive
microbial exposure did not further aggravate injury of the terminal ileum. Chronic IA UP
exposure caused significant structural ENS alterations characterized by loss of PGP9.5
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and S100β immunoreactivity, whereas these changes were not found after re-exposure
of chronic UP-exposed fetuses to LPS for 2 or 7 days.
Conclusion: The in utero loss of PGP9.5 and S100β immunoreactivity following chronic
UP exposure corresponds with intestinal changes in neonates with NEC and may
therefore form a novel mechanistic explanation for the association of chorioamnionitis
and NEC.
Keywords: Ureaplasma parvum, intra-amniotic infection, chorioamnionitis, enteric nervous system, sheep,
preterm birth, necrotizing enterocolitis
INTRODUCTION
Preterm birth is a common and major worldwide health issue,
contributing to significant neonatal morbidity and mortality
(1). Around 1 in every 10 births are preterm, accounting
for ∼15 million premature newborns each year (2). Due
to complications, over one million premature newborns will
die shortly after birth (3, 4). Chorioamnionitis, defined as
inflammatory cell infiltration of fetal membranes, is frequently
associated with preterm birth and typically occurs due to an
ascending bacterial infection (5–7) that can be acute or chronic
(8). Intrauterine exposure of preterm infants to chorioamnionitis
is associated with an increased risk of adverse neonatal outcomes
(9, 10), including necrotizing enterocolitis (NEC) (9, 11, 12).
Adverse gastrointestinal outcomes have been associated with
both systemic fetal inflammatory response syndrome (FIRS)
and direct exposure of the gut to the swallowed infected
amniotic fluid (11, 13, 14). Chorioamnionitis can occur with
intact membranes, which is common for genital mycoplasmas,
such as Ureaplasma species (spp.), present in the lower genital
tract of women (6, 15). Ureaplasma spp. can cause chronic
chorioamnionitis that does not evoke a maternal response,
but is still associated with adverse fetal outcomes (16). In an
experimental large animal model, we previously showed that a
Ureaplasma parvum (UP) serovar 3 infection up to 14 days prior
to delivery causes fetal gut inflammation with damaged villus
epithelium, gut barrier loss, and severe villus atrophy (17).
The injury caused by intrauterine Ureaplasma spp. exposure
might derive from the direct inflammatory reaction, as well
as from potential interactions with other inflammatory stimuli.
Chorioamnionitis is often polymicrobial, as over 65% of positive
amniotic fluid cultures lead to the identification of two or more
pathogens (7). In this context, we previously showed that cerebral
and lung immune activation following intra-amniotic (IA)
Abbreviations: AU, Arbitrary unit; BSA, Bovine serum albumin; CD3,
Cluster of differentiation 3; CCU, Color-changing units; CHAT, Choline
acetyltransferase; ENS, Enteric nervous system; FCS, Fetal calf serum; FIRS,
Fetal inflammatory response syndrome; GAPDH, Glyceraldehyde 3-phosphate
dehydrogenase; GFAP, Glial fibrillary acidic protein; IA, Intra-amniotic; IBD,
Inflammatory bowel disease; IL, Interleukin; IRAK3, Interleukin-1 receptor-
associated kinase 3; LPS, Lipopolysaccharide; MPO, Myeloperoxidase; NEC,
Necrotizing enterocolitis; NGS, Normal goat serum; nNOS, Neuronal nitric oxide
synthase; PBS, Phosphorylated buffer saline; PGP9.5, Protein gene product 9.5;
PPIA, Peptidylprolyl isomerase A; RPS15, Ribosomal protein S15; Spp, Species;
TLR, Toll-like receptor; TNF-α, Tumor necrosis factor alpha; UP, Ureaplasma
parvum.
lipopolysaccharide (LPS) exposure was prevented when these
animals were chronically pre-exposed to UP serovar 3 (18, 19).
This illustrates that interactions between different microbes can
occur, leading to organ-specific sensitization or preconditioning.
The enteric nervous system (ENS) consists of enteric neurons
and glial cells, autonomously regulates gastrointestinal activity
(i.e., secretion, absorption, and motility), and contributes to gut
integrity (20). The formation of the ENS requires coordinated
migration, proliferation, and differentiation of neural crest
progenitors, directed neurite growth, and establishment of a
network of interconnected neurons and glia (21, 22). Although
these processes mostly occur in utero, an important part of ENS
development takes place postnatally (23, 24). Neonates with NEC
have structural and functional damage of the submucosal and
myenteric plexus, including loss of enteric neurons and glial cells
(25–27). The involvement of chorioamnionitis in the induction of
adverse intestinal outcomes including NEC, combined with the
presence of ENS abnormalities in NEC, prompted us to study the
impact of an antenatal infection on the ENS.
The aim of this study was therefore to investigate the effect
of acute IA exposure to LPS and chronic exposure to UP on the
intestinal mucosa and ENS in fetal lambs using a well-established
sheep model of chorioamnionitis. In addition, we investigated
the potential interactions of repetitive IA microbial stimuli by
acute exposure to LPS in ovine fetuses that were chronically
pre-exposed to UP.
MATERIALS AND METHODS
Animal Model and Experimental
Procedures
All experiments were approved by the animal ethics committee
of the University of Western Australia (Perth, Australia).
The animal model and experimental procedures were
previously described (18). Briefly, 39 date-mated merino ewes
were randomly assigned to six different groups of between five
and eight animals to receive IA injections under ultrasound
guidance. Verification of the IA injections was done by amniotic
fluid electrolyte analysis. The date-mated pregnant ewes received
an IA injection of an in vitro cultured strain HPA5 of UP serovar
3 (2 × 105 color-changing units, CCU) (28) 42 days prior to
delivery (at 82 days of gestation, which corresponds to the second
trimester in humans) or Escherichia coli-derived LPS (O55:B5;
Merck, Darmstadt, Germany), 10mg in 2ml of saline, 2 or 7 days
prior to delivery (at respectively, 122 and 117 days of gestation).
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Previously, we have shown that the half-life time of LPS in the
amniotic fluid is relatively long (1.7 days) and that the LPS
amount is higher than the essential threshold of 1mg for at least
5 days (29, 30). Chronic sustained UP infection was confirmed
by positive culture of amniocentesis samples at intermediate
time points and sterile amniotic fluid samples collected at
cesarean delivery, as previously described (31). Two or seven days
LPS exposure (prior to cesarean delivery) represents an acute
inflammatory challenge. To evaluate the combined effect between
these inflammatory modalities, a subgroup of chronically UP-
infected ewes received IA LPS at 35 and 40 days post-UP infection
(i.e., 7 or 2 days LPS exposure prior to delivery following 42 days
of UP infection). A group receiving IA injections of sterile saline
(2 or 7 days prior to delivery, respectively six and two animals
which were pooled) served as controls (Figure 1). Fetuses were
surgically delivered at 124 ± 2 days of gestational age (term
gestation in sheep = 150 days), equivalent of ∼30 weeks of
human gestation. After delivery, fetuses were euthanized with
intravenous pentobarbitone (100 mg/kg). For this experiment,
fetuses of both sexes were used.
Sampling
During necropsy, blood and terminal ileum samples were
collected. Ileum samples were fixed in 10% formalin and
embedded in paraffin, or snap frozen in liquid nitrogen. Where
insufficient paraffin-embedded material was available for study,
additional material was generated by paraffin embedding snap-
frozen tissue samples: frozen tissue blocks were defrosted,
fixed in 4% formaldehyde at room temperature overnight, and
transferred to 70% ethanol prior to embedding in paraffin with
the use of a vacuum infiltration processor.
Antibodies
The following antibodies were used for immunohistochemistry:
polyclonal rabbit anti-myeloperoxidase (MPO; A0398,
Dakocytomation, Glostrup, Denmark) for the identification
of neutrophils, polyclonal rabbit anti-cluster of differentiation
3 (CD3; A0452, Dakocytomation) for the detection of T
cells, polyclonal rabbit anti-bovine protein gene product
9.5 (PGP9.5; Z5116, Dakocytomation) for the detection of
enteric neurons, polyclonal rabbit anti-doublecortin (Ab18723,
Abcam, Cambridge, UK) for the detection of immature neurons,
polyclonal rabbit anti-glial fibrillary acidic protein (GFAP; Zo334,
Dakocytomation) to detect enteric glial cell reactivity/activation
(32), and polyclonal rabbit anti-S100β (PA5-16257, Invitrogen,
Carlsbad, CA, USA) as a marker for enteric glial cells.
The following secondary antibodies were used: peroxidase-
conjugated polyclonal goat anti-rabbit (111-035-045, Jackson,
West Grove, PA, USA) (MPO), peroxidase-conjugated polyclonal
swine anti-rabbit (P0399, DakoCytomation) (doublecortin)
and BrightVision+ Poly-HRP-Anti Mouse/Rabbit IgG
biotin-free (ImmunoLogic, Duiven, Netherlands) (PGP9.5),
and biotin-conjugated polyclonal swine anti-rabbit (E0353,
DakoCytomation) (CD3, GFAP, S100β).
Immunohistochemistry
Formalin-fixed terminal ileum was embedded in paraffin and
4µm sections were cut. After deparaffinization and rehydration,
endogenous peroxidase activity was blocked with 0.3% H2O2
diluted in phosphorylated buffer saline (PBS, pH 7.4). Antigen
retrieval was performed with citrate buffer for CD3, PGP9.5,
doublecortin, and S100β stainings. Non-specific binding was
blocked for 30min at room temperature with 10% normal goat
serum (NGS) in PBS (MPO), 5% NGS in PBS (doublecortin),
or 5% bovine serum albumin (BSA) in PBS (CD3, GFAP,
and S100β). For PGP9.5, non-specific binding was blocked for
10min at room temperature with 20% fetal calf serum (FCS).
Thereafter, sections were incubated with the primary antibody
of interest and subsequently incubated with the respective
secondary antibody. MPO, PGP9.5, and doublecortin were
detected by using a peroxidase-conjugated secondary antibody
and antibodies against CD3, GFAP, and S100βwere detected with
FIGURE 1 | Different intervention study groups. All injections were delivered by ultrasound-guided amniocentesis. Timing is shown in gestational days.
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TABLE 1 | Primer sequences.
Primer Forward Reverse
RPS15 5′-CGAGATGGTGGGCAGCAT-3′ 5′-GCTTGATTTCCACCTGGTTGA-3′
GAPDH 5′-GGAAGCTCACTGGCATGGC-3′ 5′-CCTGCTTCACCACCTTCTTG-3′
PPIA 5′-TTATAAAGGTTCCTGCTTTCACAGAA-3′ 5′-ATGGACTTGCCACCAGTACCA-3′
IL-1β 5′-AGAATGAGCTGTTATTTGAGGTTGATG-3′ 5′-GTGAGAAATCTGCAGCTGGATGT-3′
IL-6 5′-ACATCGTCGACAAAATCTCTGCAA-3′ 5′-GCCAGTGTCTCCTTGCTGTTT-3′
IL-10 5′-CATGGGCCTGACATCAAGGA-3′ 5′-CGGAGGGTCTTCAGCTTCTC-3′
TNF-α 5′-GCCGGAATACCTGGACTATGC-3′ 5′-CAGGGCGATGATCCCAAAGTAG-3′
IRAK3 5′-AGTGTGTAGGTAACACAGCCC-3′ 5′-TGCTGGTCATGCTTATGGCA-3′
nNOS 5′-CGGCTTTGGGGGTTATCAGT-3′ 5′-TTGCCCCATTTCCACTCCTC-3′
CHAT 5′-CCGCTGGTATGACAAGTCCC-3′ 5′-GCTGGTCTTCACCATGTGCT-3′
avidin–biotin complex (Vectastain Elite ABC kit, Bio-connect,
Huissen, Netherlands). Substrate staining was performed for
MPO with 3-amino-9-ethylcarbazole (AEC; Merck, Darmstadt,
Germany). Immunoreactivity for CD3 andGFAPwas detected by
using nickel-DAB. Immunoreactivity for PGP9.5, doublecortin,
and S100β was detected by using DAB. Hematoxylin (MPO,
PGP9.5, doublecortin, and S100β) or nuclear fast red (CD3 and
GFAP) was used as a counterstain for nuclei.
Qualitative Analysis of Damage of the
Terminal Ileum
H&E slides were analyzed by two independent investigators
blinded to the experimental setup to assess damage of the
terminal ileum. A scoring system from 0 to 4 was used to describe
the severity of histological injury. Scoring was as follows: 0, no
damage; 1, disrupted epithelial lining, but no loss of enterocytes;
2, disrupted epithelial lining, mild enterocyte loss from the villus
tips; 3, disrupted epithelial lining, moderate enterocyte loss from
villus tips, some debris in the lumen; and 4, abundant enterocyte
loss from villus tips, abundant debris in the lumen, and severe
shedding of villus tips.
Quantification of Immunohistochemical
Stainings
The stained tissue sections were scanned with the Ventana iScan
HT slide scanner (Ventana Medical Systems, Oro Valley, AZ,
USA). Of these images, viewed with Panoramic Viewer (version
1.15.4, 3DHISTECH, Budapest, Hungary), random images of
regions of interest were taken (×200).
Two investigators blinded to the study groups counted the
MPO- and CD3-positive cells in three to five non-overlapping
high-power fields in the mucosa and submucosa. The average
MPO- and CD3-positive cells per area are reported for each
animal. The percentage of area in the submucosal and myenteric
ganglia positively stained for PGP9.5, doublecortin, GFAP, and
S100β was determined in five non-overlapping high-power
fields using Leica QWin Pro software (version 3.4.0, Leica
Microsystems, Mannheim, Germany) by an investigator blinded
to the study groups. Relative area staining was calculated by
dividing the positively stained areas of the ganglia of the
submucosal or myenteric plexus by the total area of the
muscle layer. The data are expressed as fold increase over the
control value.
RNA Extraction and Quantitative
Real-Time PCR
RNA was extracted from snap-frozen terminal ileum tissue
using TRI reagent (Invitrogen)/chloroform extraction. Isolated
RNA was DNase treated to remove possible contamination
with genomic DNA by using the RQ1 RNase-Free DNase
kit (Promega, Madison, WI, USA) and afterwards reverse
transcribed into cDNA using oligo(dT)12–18 primers
(Invitrogen) and Moloney murine leukemia virus (M-MLV)
reverse transcriptase (Invitrogen). Quantitative real-time PCR
(qPCR) reactions were performed with a LightCycler 480
Instrument (Roche Applied Science, Basel, Switzerland) using
the SensiMixTM SYBR R© No-ROX kit (Bioline, London, UK) for
45 cycles. The mRNA levels of IL-1β , IL-6, IL-10, tumor necrosis
factor alpha (TNF-α), and interleukin-1 receptor-associated
kinase 3 (IRAK3) were determined to assess inflammation
of the terminal ileum. The mRNA levels of neuronal nitric
oxide synthase (nNOS) and choline acetyltransferase (CHAT)
were determined to assess the motility signaling functions of
the ENS using LinRegPCR software (version 2016.0, Heart
Failure Research Center, Academic Medical Center, Amsterdam,
Netherlands). The geometric mean of the mRNA levels of three
reference genes [ribosomal protein S15 (RPS15), glyceraldehyde
3-phosphate dehydrogenase (GAPDH), and peptidylprolyl
isomerase A (PPIA)] were calculated and used as a normalization
factor. The data are expressed as fold increase over the control
value. The primer sequences are shown in Table 1.
Data Analysis
Data are presented as median with interquartile range. Statistical
analyses were performed using GraphPad Prism (version 6.01,
GraphPad Software Inc., La Jolla, CA, USA). A non-parametric
Kruskal–Wallis test followed by Dunn’s post hoc test was used
to analyze statistically significant group differences. Differences
were considered statistically significant at p < 0.05. Given the
relatively small animal numbers per group, we also reported
actual p values between p ≥ 0.05 and p < 0.10 and interpreted
these as potentially biologically relevant. This assumption will
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FIGURE 2 | Increased mucosal injury in all groups, except for the animals
exposed to 2 days LPS. #p = 0.06, *p < 0.05, **p < 0.005 compared to the
control.
decrease the chance of a type II error, but increases the chance
of a type I error.
RESULTS
Intestinal Damage and Inflammation in the
Terminal Ileum Due to Chorioamnionitis
There was a higher intestinal damage score for all experimental
groups compared to the control (p < 0.005 for the 7 days LPS
group, p < 0.05 for the 42 days UP group and 42 days UP +
7 days LPS group, and p = 0.06 for the 42 days UP + 2 days
LPS group all compared to the control; Figure 2), except for the
animals exposed to 2 days of LPS. Pre-exposure with UP did not
augment mucosal injury in the LPS-treated groups.
A statistically significant increase in MPO-positive cells was
seen in the mucosa 7 days after LPS exposure compared to
the control (p < 0.05; Figure 3). Chronic UP infection also
caused an elevation of mucosal MPO-positive cells compared
to the control (p = 0.08; Figure 3). Furthermore, combining
these two inflammatory insults resulted in an increased mucosal
MPO-positive cell count compared to the control (p < 0.005;
Figure 3), and this experimental group tended to be increased
when compared to the UP+ 2 days LPS-exposed group (p= 0.07;
Figure 3). LPS exposure 2 days prior to delivery was insufficient
to induce mucosal MPO-positive cell infiltration. Pre-exposure
to UP in combination with LPS administration did not alter the
number of mucosal MPO-positive cells compared to LPS alone,
both after 2 and 7 days.
While chronic UP infection and acute LPS exposure 2 days
pre-delivery did not have any effect on mucosal CD3-positive T
cell presence, those animals receiving LPS 7 days pre-delivery
(both uninfected and chronic UP-infected groups) as well as
chronic UP-infected animals receiving LPS 2 days pre-delivery
all showed apparent elevated levels of CD3-positive T cell
infiltration (Figure 4). However, the only comparison to achieve
p < 0.05 significance was that of uninfected and chronic UP-
infected animals receiving LPS 2 days pre-delivery (Figure 4).
For investigation of submucosal inflammation, there was an
increase of MPO-positive cells in the 7 days LPS group and
submucosal MPO-positive cells tended to be increased in the
chronic UP infection group compared to the control (p < 0.05
and p = 0.06; Figure 5). Additional acute LPS insult (2 or 7
days pre-delivery) in chronic UP-infected animals resulted in
increased variability and loss of significance in the MPO cell
infiltration compared to 2 or 7 days of LPS alone.
The greatest increase of submucosal CD3-positive cells was
observed in 2 day LPS-exposed chronic UP-infected animals,
which was significantly increased compared to the control or
acute 2 day LPS stimulation alone (both p < 0.05; Figure 6)
and appeared more potent than in chronic UP-infected animals
receiving LPS at 7 days pre-delivery (p= 0.08; Figure 6).
Examination of underlying cytokine levels revealed increased
IL-1β mRNA levels only in the uninfected or chronic UP-infected
animals when LPS was administered 2 days pre-delivery (p <
0.05 compared to the 7 days LPS group, p < 0.01 compared
to the 42 days UP group, p < 0.05 compared to the 42 days
UP + 7 days LPS group, and p < 0.05 compared to the
control, respectively; Figure 7A), whereas IL-1β mRNA levels
had dropped to baseline again if LPS was administered 7 days
pre-delivery (Figure 7A). IL-6 and IL-10 mRNA levels were not
altered (data not shown), and the only group showing apparent
TNF-αmRNA level elevation was that of the chronic UP-infected
animals additionally receiving LPS 2 days pre-delivery (p= 0.07;
Figure 7B).
IRAK3 mRNA levels were increased significantly only in
animals exposed to 2 days of LPS alone compared to the control
(p< 0.05; Figure 7C).
ENS Alterations in the Terminal Ileum Due
to Chronic IA UP Exposure
The PGP9.5-positive surface area in the submucosal plexus
tended to be decreased in animals chronically infected for 42 days
with UP compared to the control (p = 0.08; Figure 8). Similarly,
chronic UP-infected animals had a diminished PGP9.5-positive
surface area in the myenteric plexus (p < 0.05; Figure 8).
Doublecortin-positive surface areas were not altered in either the
submucosal or the myenteric plexus (data not shown).
In the submucosal plexus, the GFAP-positive surface area
tended to be increased in groups receiving LPS either 2 or 7
days pre-delivery compared to the control (p = 0.07 and p =
0.09; Figure 9), while in the myenteric plexus, the GFAP-positive
surface area was only increased in the group receiving LPS 7
days pre-delivery compared to the control (p < 0.05; Figure 9).
For both of these regions, concomitant chronic infection by UP
appeared to mute these effects.
S100β-positive surface areas were unaltered in the submucosal
plexus for all conditions (data not shown), while in the myenteric
plexus, the S100β-positive surface area was significantly
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FIGURE 3 | Representative images of mucosal neutrophil influx reflected by myeloperoxidase (MPO)-positive cell (indicated by white triangles) counts of the control
(A), 7 days lipopolysaccharide (LPS) (B), Ureaplasma parvum (UP) (C), and UP prior to 7 days LPS groups (D). (E) Increased MPO count in animals exposed to 7
days LPS, UP, and UP prior to 7 days LPS. #p = 0.08, *p < 0.01, **p < 0.005 compared to the control.
decreased in the chronic UP-infected group compared to the
control (p < 0.05; Figure 10), but this effect appeared to be
counteracted by acute stimulation by LPS at either 2 or 7 days
pre-delivery. No differences in nNOS and CHAT expression were
observed between the groups (data not shown).
DISCUSSION
In this study, we investigated the effect of acute, chronic, and
combined microbial exposure as an antenatal infectious trigger
(chorioamnionitis) on the mucosa, submucosa, and ENS of the
terminal ileum of premature lambs.
Both acute LPS and chronic UP exposure caused mucosal
inflammation and injury to the terminal ileum. Although the
inflammatory signature differed between these groups, mucosal
injury was not aggravated in the combined exposure groups.
Prenatal IA exposure to 7 days of LPS and to chronic 42 days
infection by UP both provoked an influx of neutrophils (MPO-
positive cells) in the intestine. In contrast, T cell (CD3-positive
cells) numbers remained unaltered in the chronic UP and 2 days
LPS groups compared to the control group, but were increased
in the UP + 2 days LPS-exposed animals, indicating a potential
synergistic effect of both inflammatory stimuli in inducing an
adaptive mucosal immune response. We observed a similar effect
in the submucosa: while either LPS exposure or UP infection
induced innate immune changes in the ileum, T cell alterations
only occurred in the presence of combined UP and LPS exposure.
Based on the current findings, we can only speculate on the
mechanism behind this synergistic effect. In previous in vitro
studies, signaling via Toll-like receptors (TLR) 1, 2, and 6 by
Ureaplasma spp. increased LPS-mediated inflammation (33, 34).
Additionally, TNF-α mRNA levels tended to be increased in the
UP-infected animals receiving LPS 2 days pre-delivery, while
TNF-α levels were not increased upon single exposure to either
UP or LPS alone. In contrast, no synergistic effect of UP and
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FIGURE 4 | Representative images of mucosal T cell influx reflected by CD3-positive cell (indicated by white triangles) counts of the control (A) and Ureaplasma
parvum (UP) prior to 2 days lipopolysaccharide (LPS) (B). (C) Increased CD3 count in animals exposed to UP prior to 2 days LPS compared to the 2 days LPS group.
FIGURE 5 | Representative images of submucosal neutrophil influx reflected by myeloperoxidase (MPO)-positive cell (indicated by white triangles) counts of the
control (A), 7 days lipopolysaccharide (LPS) (B) and Ureaplasma parvum (UP) (C). (D) Increased MPO count in animals exposed to 7 days LPS and UP. #p = 0.06,
*p < 0.05 compared to the control.
LPS exposure on intestinal IL-1β mRNA levels was found in the
current study. This is supported by our IRAK3 mRNA findings,
a negative regulator of TLR signaling (35), which remained
unaltered in combined exposure of UP-infected animals to LPS.
Based on these joined findings, it is tempting to speculate that
UP + LPS induced the upregulation of cell adhesion molecules
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FIGURE 6 | Representative images of submucosal T cell influx reflected by CD3-positive cell (indicated by white triangles) counts of the control (A) and Ureaplasma
parvum (UP) prior to 2 days lipopolysaccharide (LPS) groups (B). (C) Increased CD3 count in animals exposed to UP prior to 2 days LPS. *p < 0.05 compared to the
control.
FIGURE 7 | Relative mRNA levels of IL-1β (A), TNF-α (B), and IRAK3 (C) in arbitrary unit (AU). (A) Increased IL-1β mRNA level in animals exposed to 2 days
lipopolysaccharide (LPS) and Ureaplasma parvum (UP) prior to 2 days LPS. *p < 0.05 compared to the control. (B) Increased TNF-α mRNA level in animals exposed to
UP prior to 2 days LPS. #p = 0.07 compared to the control. (C) Increased IRAK3 mRNA level in animals exposed to 2 days LPS. *p < 0.05 compared to the control.
and, consequently, temporarily increased diapedesis, which could
at least in part be responsible for the observed increase in CD3-
positive cells. The latter suggestion is supported by previous in
vitro findings showing enhanced endothelial protein expression
of the cell adhesion molecule CXCR7 following co-incubation
with LPS and UP, which was not observed in independently UP-
or LPS-exposed cells (36).
Interestingly, other ovine studies have reported a suppressive
immune effect in the premature lung and brain after chronic UP
exposure prior to acute LPS exposure (18, 19). Taken together,
these data show that cells might be sensitized, preconditioned,
or remain unaffected following chronic UP infection, indicating
organ-dependent responses. The mechanisms responsible for
organ-specific effects of a second-hit chorioamnionitis remain to
be elucidated.
The ENS closely interacts with intestinal immune cells
(37). As such, ENS alterations can both result from intestinal
inflammation and modulate it (38, 39). In this study, the most
evident signs of ENS alterations were seen after chronic UP
infection, which caused a reduced PGP9.5-positive surface area
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FIGURE 8 | Representative images of PGP9.5 immunoreactivity in the submucosal and myenteric plexus of the control (A) and Ureaplasma parvum (UP) (B) groups.
Area fraction of PGP9.5 in the submucosal plexus (C) and myenteric plexus (D) as fold increase over the control value. (C) PGP9.5-positive surface area tended to be
decreased in the submucosal plexus of animals exposed to UP. #p = 0.08 compared to the control. (D) Decreased PGP9.5-positive surface area in the myenteric
plexus of animals exposed to UP. *p < 0.05 compared to the control.
FIGURE 9 | Representative images of glial fibrillary acidic protein (GFAP) immunoreactivity in the submucosal and myenteric plexus of the control (A), 2 days
lipopolysaccharide (LPS) (B), and 7 days LPS (C) group. Area fraction of GFAP in the submucosal plexus (D) and myenteric plexus (E) as fold increase over the control
value. (D) The GFAP-positive surface area tended to be increased in the submucosal plexus of animals exposed to 2- and 7 days LPS. ##p = 0.07, #p = 0.09
compared to the control. (E) Increased GFAP-positive surface area in the myenteric plexus of animals exposed to 7 days LPS. *p < 0.05 compared to the control.
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FIGURE 10 | Representative images of S100β immunoreactivity in the submucosal and myenteric plexus of the control (A) and Ureaplasma parvum (UP) group (B).
Area fraction of S100β in the myenteric plexus (C) as fold increase over the control value. (C) The S100β-positive surface area was decreased in the myenteric plexus
of animals exposed to UP. *p < 0.05 compared to the control.
in both plexuses, likely representing a loss of enteric neurons.
Alternatively, this might represent a loss of PGP9.5 positivity by
enteric neurons. The doublecortin-positive (immature neurons)
surface area in chronically UP-infected animals was unchanged,
indicating that a decrease of mature neurons is responsible
for the observed neuronal cell loss. As the period between 10
and 18 weeks of gestation is considered to be of paramount
importance for both morphological and functional maturation
of the ENS (40, 41), one might assume that the timing
of our inflammatory challenge during this vulnerable second
trimester is the key determinant for the observed effects rather
than the nature of the microbial trigger. The loss of enteric
neurons in the myenteric plexus following chronic UP infection
coincides with a reduced S100β-positive surface area, suggesting
a reduced number of enteric glial cells. However, a reduction
of S100β immunoreactivity within glial cells could be involved
in the observed effect as well. Enteric glial cells are known
to contribute to neuronal maintenance, survival, and function
(42). Interestingly, the S100β-positive surface area was less
reduced in the groups exposed to an additional LPS challenge
in combination with chronic UP infection, and the median of
the PGP9.5-positive surface area was higher in these groups.
In support, previous studies have shown that enteric glial cells
are capable of generating enteric neurons in response to injury
(43, 44), indicating that glial cells could be the driving cells
behind the loss or gain of neurons in our model. As a hallmark
of their high level of cellular plasticity (45), enteric glia can
respond to inflammatory cues and ENS damage by alternating
their morphology and the expression of key proteins such as
GFAP, in a process similar to reactive astrogliosis (46, 47). In this
study, GFAP immunoreactivity was increased in both plexuses
in the LPS-exposed animals, indicating that a glial response is
induced by intestinal inflammation (48). An enteric glial cell
response was not detected in chronic UP-infected animals despite
signs of intestinal inflammation, suggesting normalization of the
GFAP levels within this period. Interestingly, pre-conditioning
through chronic UP infection prevented GFAP upregulation in
response to the overlapping second challenge with LPS in the
glial cells in both plexuses, as no altered GFAP immunoreactivity
was seen following subsequent IA LPS exposure. Whether this
is solely protective or can contribute to the ENS damage seen
in chronic UP exposure is unclear, as activation of enteric glia
in the context of intestinal inflammation has been described
to be both destructive (49) and potentially neuroregenerative
(50). We may conclude from the aforementioned findings that
enteric glial cells are already able to react to inflammatory cues
prenatally. Importantly, our results suggest that these cells play
an important role in neuronal survival and neurogenesis in the
intrauterine setting.
At present, the postnatal consequences of the detected loss
of mature neurons and glial cells following UP exposure in
the second trimester remain unknown. A similar decrease in
enteric neurons has been described in models of experimental
colitis, which show that neuronal loss persists after recovery
of inflammation (51) and is accompanied by a decreased
colonic motility (52). Based on these combined findings, it is
likely that the observed changes in utero will result in ENS
dysfunction postnatally.
Interestingly, several studies describe intestinal changes in
patients with acute NEC that are similar to those found after
chronic UP infection, namely, loss of both enteric neurons
(25–27, 53) and glial cells (25–27). Moreover, it has been
suggested that ablation of enteric glial cells may be an upstream
target of NEC pathology (54). A potential causal role of the
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ENS in NEC pathophysiology is further supported by a rat
study in which increased NEC survival and intestinal motility
was associated with improvement of ENS changes, including an
increase in enteric neurons (27). Collectively, our findings form
a novel mechanistic explanation for the reported association of
chorioamnionitis and NEC.
A limitation of this study is that it only enables us to study
the effects of UP and LPS exposure at one time point, preventing
us from dissecting the role of the different inflammatory triggers
(LPS and UP) of inflammation duration (acute and chronic).
In addition, the group sizes are small, which is an inherent
shortcoming of the translational ovine model used.
In summary, an acute inflammatory stimulus with LPS or a
chronic inflammatory stimulus with UP causes intestinal injury
and inflammation in the mucosal and submucosal layers of
the gut. Combined overlapping microbial exposure does not
aggravate injury of the terminal ileum.Most importantly, chronic
UP infection causes structural ENS alterations characterized by
PGP9.5 and S100β immunoreactivity loss. Whether the observed
ENS alterations result in functional abnormalities after birth
remains to be elucidated. However, the observed changes in
utero correspond with findings in neonates with NEC, which
underlines the concept that NEC pathophysiology may already
have its origin in utero.
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